Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
IQIQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV)

New York Stock Exchange · Currency in USD
$279.36 ▲ +1.04 (+0.37%)
At close: Oct 23, 4:00 PM ET. Market closed.
$279.54 ▲ +0.18 (+0.06%)
After hours: Oct 23, 5:03 PM ET

Summary

Previous Close
$278.32
Open
$276.56
Day's Range
$274.67 – $279.58
52 Week Range
$154.50 – $282.98
Volume
981,196
Avg. Volume
1,465,712
Market Cap
$45.98B
Beta (5Y Monthly)
1.17
PE Ratio (TTM)
34.36
EPS (TTM)
$8.22
Earnings Date
Oct 27, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$284.64

Profile: IQVIA Holdings Inc.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
94,000
CEO
Ari Bousbib
Website
iqvia.com

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes.

Earnings

Next report: Tue, Oct 27, 2026
EPS estimate $3.26 · Revenue est. $4.37B
DateEst.Actual
Jul 28, 2026$3.03$3.15Beat
May 5, 2026$2.82$2.90Beat
Feb 5, 2026$3.40$3.42Beat
Oct 28, 2025$2.98$3.00Beat
Jul 22, 2025$2.77$2.81Beat
May 6, 2025$2.63$2.70Beat

Analyst view

Consensus price target
$284.64 ▲ +1.9%
Range $240.00 – $345.00
Rating: Buy
Buy 82% · Hold 16% · Sell 2%

Get free alerts on IQV and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.